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AbStract
the aim of the study is to investigate 
anti-inflammatory properties of polar and 
non-polar extracts prepared from Critonia 
aromatisans and Montanoa grandiflora, two 
common native species used in Mayan tradi-
tional ointments to treat inflammation, joint 
pain and rheumatism. The anti-inflammatory 
properties of methanol/acetonitrile and n-
hexane leaf extracts were tested in vivo and 
in vitro. The extracts of C. aromatisans and 
M. grandiflora decreased in a concentra-
tion-dependent manner lipopolysaccharide 
(LPS)-induced nitric oxide (NO) production 
without affecting the cell viability. the 
extracts of C. aromatisans at dose of 200 
mg/kg exhibited substantial anti-inflamma-
tory activity in the carrageenan-induced paw 
oedema test and 12-O-Tetradecanoylphor-
bol-13-acetate (TPA)-induced ear oedema 
inhibition assay with a reduction in inflam-
mation of up to 90 and 80%, respectively. 
These results validate the traditional uses by 
Mayan communities that endorse the use of 
this species to treat inflammation.
Key words: Critonia aromatisans, Monta-
noa grandiflora, inflammation, carrageenan, 
nitric oxide, macrophages 
rESUMEN
El objetivo del estudio es investigar las 
propiedades antiinflamatorias de extrac-
tos de Critonia aromatisans y Montanoa 
grandiflora, dos especies nativas comu-
nes utilizadas en ungüentos tradicionales 
mayas para tratar la inflamación, dolor en 
las articulaciones y el reumatismo. Las 
propiedades antiinflamatorias de extractos 
metanol/acetonitrilo y n-hexánicos de hojas 
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fueron evaluados in vitro e in vivo. Los ex-
tractos de C. aromatisans y M. grandiflora 
disminuyeron la producción de óxido nítrico 
(NO) inducida por lipopolisacárido (LPS) de 
manera dependiente de la concentración sin 
afectar la viabilidad celular. Los extractos 
de C. aromatisans, a dosis de 200 mg/kg 
exhiben actividad antiinflamatoria sustancial 
en el ensayo de edema plantar inducido por 
carragenina y en el ensayo de inhibición de 
edema de la oreja inducido por TPA con una 
reducción en la inflamación de 90 y 80%, 
respectivamente. Estos resultados validan 
los usos tradicionales de las comunidades 
mayas que avalan el uso de esta especie para 
el tratamiento de la inflamación.
palabras clave: Critonia aromatisans, 
Montanoa grandiflora, inflamación, carra-
genina, óxido nítrico, macrófagos.
iNtrODUctION
In Yucatán, México, ancient Mayan knowled-
ge has provided remedies for the treatment 
of diverse ailments, especially among rural 
populations. Inflammation is a response 
induced by pathogens, damaged tissue or 
autoimmune and inflammatory diseases. 
Physiologically, inflammation operates 
in a restricted environment to erradicate 
infected or devitalized tissue. Although 
usually beneficial to the host, inflammation 
is intrinsically destructive to the imme-
diate surroundings (Ahmed et al., 1995). 
Rheumatism is a term used to describe the 
inflammation or degeneration of the connec-
tive tissues of the body, and this condition 
affects primarily the muscles, joints and 
tendons, among other tissues. Rheumatism 
can also refer to the autoimmune disease that 
leads to the deformity of muscles or joints 
(joint destruction) (Zuther, 2009). Several 
molecules are involved in the inflammatory 
response, including prostaglandins and nitric 
oxide (NO) (Gallin and Snyderman1999; 
Koeberle and Werz 2015). NO production 
by activated macrophages has been shown 
to mediate immune functions, including 
antimicrobial and antitumor activities. 
However, excess NO production has been 
implicated in inflammatory processes, septic 
shock, asthma and autoimmune diseases 
such rheumatoid arthritis (Mac Micking et 
al., 1995; Jerzynska et al., 2014).
Therefore, the inhibition of NO production 
has become a therapeutic target for the treat-
ment of inflammatory diseases (Azadmehr, 
2009; Wen-Jun. et al., 2015). 
Inflammation affects many people world-
wide, and homemade remedies prepared 
from single plants or mixtures of plants 
are used in several cultures to treat these 
symptoms. two common plants used in the 
Yucatán Peninsula to treat inflammation 
and rheumatism are Critonia aromatisans 
(Dc.) r.M. King & H. rob. and Montanoa 
grandiflora DC., members of the Asteraceae 
family. These plants are commonly used 
alone, together or in different plant mixtures 
to prepare anti-inflammatory and anti-ar-
thritis remedies. C. aromatisans (formerly 
Eupatorium hemipteropodum) is known in 
Mexico as “Chiople” and in Cuba as “Trébol 
de olor”. Mayan people traditionally apply 
the leaves to the painful area; for example, 
the leaves are applied to the forehead to 
treat migraines. The leaves are also used to 
prepare decoctions to treat oedema and can 
be used as a poultice or in ointments elabo-
rated with petrolatum (Méndez-González et 
al., 2012). The production of such ointments 
involves pulverizing the leaves and boiling 
them with petrolatum. The mixture is filtered 
and placed in containers. Then, it is ready to 
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use topically on the affected area of the body. 
The leaves have also been used to aroma-
tize tobacco (roig, 1974). this species has 
never been chemically or biologically eva-
luated. Montanoa grandiflora (Eurycoma 
hartwegiana) is known as the “daisy tree,” 
and its flowers are used ornamentally. This 
plant possesses a resinous fragrance, and 
in traditional Mayan medicine, the leaves 
are used to treat rheumatism (alone or as 
a poultice) and stomach aches (Méndez-
González et al., 2012). There are no reports 
on the biological properties of this plant. 
Therefore, the aim of this investigation was 
to evaluate the anti-inflammatory activities 
of the polar (methanolic/acetonitrile) and 
non-polar (hexanic) extracts of these two 
plants that are traditionally used to alleviate 
symptoms of inflammation.
mEtHODS
Abbreviations 
NO (nitric oxide), CA (Critonia aromati-
sans), MG (Montanoa grandiflora), MeOH 
(methanol), acn (acetonitrile), hx (hexane), 
DMSO (dimethyl sulfoxide), tPa (12-O-
tetradecanoylphorbol-13-acetate), DMEM 
(Dulbecco’s Modified Eagle Medium), MTT 
( 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide), CAacn (MeOH/acn 
extract from C. aromatisans), cahx (hx ex-
tract from C. aromatisans), MGacn (MeOH/
acn extract from M. grandiflora), MGhx 
(hexanic extract from M. grandiflora).
plant material
Leaves from C. aromatisans (871.2 g) and 
M. grandiflora (127.3 g) were collected from 
the botanical garden of the Traditional Medi-
cal Centre of Yaxcabá, Yucatán, México. at 
1 km N of the road to “Libre Unión” town. 
Both species were collected in June 2010 
and were identified by taxonomist professor 
Mendez-González. A voucher specimen of 
each plant was deposited at the Herbarium 
“Roger Orellana” of the Centro de Investi-
gación Científica de Yucatán (CICY) under 
the collection numbers A. Dorantes 134 
(C. aromatisans) and M. Méndez 1754 (M. 
grandiflora).
preparation of the extracts
Powdered leaves of the plants were extracted 
with methanol (MeOH) at room temperature 
(three times) to obtain the C. aromatisans 
(243 g) and M. grandiflora (21 g) MeOH 
extracts. A portion of each methanolic 
extract (1 g) was dissolved in MeOH, and 
then acetonitrile (acn) was added (1:3). This 
mixture was extracted with hexane, and 
then, both phases were separated to obtain 
the non-polar hexanic (CAhx and MGhx) 
and polar MeOH/acn fractions (CAacn and 
MGacn).
in vitro assays
isolation and cell culture of peritoneal 
macrophages
Macrophages were isolated from the peri-
toneal cavities of male ICR mice. Briefly, 
macrophages were harvested immediately 
by lavage with 10 mL of cold sterile PBS 
injected into the peritoneal cavity of each 
mouse, and the resultant exudates were 
immediately collected, washed two times 
with PBS, re-suspended and adjusted to 
1x106 cells/mL in DMEM containing 10% 
inactivated foetal bovine serum, 100 U/mL 
penicillin and 100 µL streptomycin (referred 
to as complete DMEM). Fifty-microliter 
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aliquots of the cell suspension (5 x 104 
cells/well) were cultured in 96-well plates 
with 200 µL of complete DMEM for 24 h 
at 37ºC in a humidified 5% CO2 incubator. 
Non-adherent cells were removed by gentle 
washing with DMEM, and then, freshly pre-
pared medium containing the plant extracts 
was added. 
treatment of peritoneal macrophages
Purified peritoneal macrophages (5×104 
cells/well) were incubated with the plant ex-
tracts at different concentrations (1, 10, 100, 
500 and 1000 µg/mL). A control group trea-
ted with DMEM was included. the plates 
were maintained at 37ºC in a humidified 5% 
cO2 incubator. After incubation, the super-
natants were removed, and LPS (1 µg/mL) 
was added to the culture. The supernatants 
were collected after 72 h of LPS treatment 
for nitrite determination.
measurement of nitrite production
Nitrite production, an indicator of NO 
synthesis, was determined by the Griess 
reaction (Green, 1982). Briefly, 50 µL of 
supernatant from each well of the 96-well 
plates were incubated with an equal volume 
of Griess reagent (1% sulphanilamide/0.1% 
naphthalene diamine dihydrochloride/2.5% 
H3PO4) for 10 min at room temperature to 
quantify the level of nitrite (Ding, 1988). 
The absorbance was determined at 550 nm 
using a microplate reader. The relationship 
between the absorbance and the concentra-
tion of NO was determined using dilutions of 
sodium nitrite in culture medium with known 
concentrations (0-100 µM) as standards.
determination of cell viability
cell viability was assessed using the mito-
chondrial-dependent reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) to purple formazan. 
Cells were obtained as described previously 
and were plated in a 96-well culture dish at 
a concentration of 5×104 cells/well in com-
plete DMEM. After an overnight incubation, 
the cells were washed with DMEM, and 
subsequently, various concentrations of the 
tested extracts at 1, 10, 100, 500 and 1000 
µg/mL were added in a total volume of 200 
µL of medium. The cells were then cultured 
for 24 h at 37ºC in a humidified 5% CO2 
incubator. The supernatants were removed, 
and the cells were incubated with MTT (5 
mg/mL in PBS) for 4 h at 37ºC and 5% CO2. 
After this incubation, the formazan crystals 
formed were dissolved in DMSO. The extent 
of the reduction of MTT was quantitated by 
measuring the absorbance at 550 nm using 
a microplate reader. The proliferation per-
centage was calculated using the following 
equation: 
% proliferation = (OD sample-OD control/
OD control) x 100
in vivo assays
Animals
Male and female balb/c mice (20-25 g) 
were purchased from the Animal Breeding 
laboratories of CIBO-IMSS (Guadalajara, 
Jalisco, Mexico). ICR mice (20-25 g) were 
provided from the Animal House of Centro 
de Investigaciones Regionales “Dr. Hideyo 
289
Villa-De la Torre, F. et al.: Anti-inflammatory activity of Critonia aromatisans and Montanoa grandiflora leaves extracts.
ISSN 2395-9525 
Noguchi”-UADY (Mérida, Yucatán, México). 
The animals were provided a standard pe-
llet diet and water ad libitum. Five animals 
were used in each group. The animals were 
processed according to the ethical guideli-
nes for Mexican procedures (Norma oficial 
Mexicana NOM-062-ZOO, 1999).
preparation of test samples 
Mice were weighed and then treated per 
os with 200 mg/kg of extract previously 
dissolved in a solution of 5% tween 80 in 
water. The control group received 100  µL 
of 5% Tween 80 in pure water and received 
the same experimental handling as the test 
groups. The anti-inflammatory drug indo-
methacin (10 mg/kg) was used as a positive 
control (Boughton-Smith, 1993).
carrageenan-induced hind paw oedema 
in Balb/c mice
the in vivo anti-inflammatory activity was 
evaluated using the carrageenan-induced 
hind paw oedema model with slight mo-
difications (Winter, 1962). Briefly, four 
experimental groups and two control groups 
(positive and negative) were formed. Five 
Balb/c mice were included in each group 
and 30 min after the oral administration 
(200 mg/kg) of the test sample or vehicle, 
a suspension of carrageenan (Sigma, St. 
Louis, MO, USa) at 1% (0.25 µL/ paw) in 
sterile physiological saline solution (0.9%) 
was injected into the subplantar tissue of the 
right hind paw of each mouse. The thickness 
of the hind paw was measured before oral 
administration and 3 h after injection with 
carrageenan. The difference in footpad 
thickness was measured using a precision 
micrometer. The mean values of treated 
groups were compared with the mean values 
of the untreated control group (negative 
control), and the percentage inhibition of 
inflammation was calculated.
tpA-induced mouse ear oedema
Four experimental groups and two control 
groups (positive and negative) were formed, 
with five Balb/c mice in each group. Briefly, 
2.5 µg of TPA (12-O-tetradecanoylphorbol-
13-acetate) dissolved in 20 µL of acetone 
was applied to each side of the right ear 
of each mouse in the experimental groups. 
This thickness of the ear was measured 
before oral administration and 3 h after 
the TPA was applied. The difference in ear 
thickness was measured using a precision 
micrometer. The mean values of the trea-
ted groups were compared with the mean 
values of the untreated control group, and 
the percentage inhibition of inflammation 
was calculated. 
Acute oral toxicity
Acute oral toxicity was assessed in a short-
term observation period of 72 h over mor-
bidity and mortality of the animals (OECD, 
2001). The mice were treated with a single 
dose of 200 mg/kg of the polar and non-
polar extracts of C. aromatisans and M. 
grandiflora. The mice were observed for 
4 h after the administration of the samples, 
paying special attention to the changes and 
alterations in behaviour and appearance of 
the fur. The observations were continued 
for 1 h each day. The following indicators 
of toxicity were assessed and recorded: 
breathing, pruritus, lethargy, appearance 
of the fur, excessive consumption of water, 
changes in eyes and mucous membranes, 
walking alterations, position, manipulation, 
drowsiness, self-cleanliness, convulsions, 
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salivation, diarrhoea, auto mutilation, coma 
and death.
Gc-ms Analysis
Preliminary analyses of the n-hexanic 
extracts were performed by gas chromato-
graphy/mass spectrometry with an Agilent 
technologies 6890N system equipped with 
an HP-5 MS capillary column (30 m × 25 
mm x 0.25 µm). Helium was used as the 
carrier gas; the injection volume was one 
microliter, and the temperature program 
used was as follows: 50°c (3 min); an initial 
temperature of 80°C (5 min.); an increase to 
215°C at 4°C/min; and a hold at 215°C for 
5 min. The identification of the components 
was based on the comparison of their mass 
spectra fragmentation with those reported in 
the NIST05 compounds library. 
statistical analysis
For cell viability, experimental values are 
expressed as the mean ± standard deviation 
of at least three experiments performed in 
triplicate. The data were analysed using one-
way aNOVa with Dunnett’s multiple com-
parisons test. For in vivo pharmacological 
evaluations, experiments were performed 
with five animals per group. For in vivo 
and in vitro tests, experimental values are 
expressed as the mean ± standard error of 
the mean (S.E.M.). Statistical analysis was 
performed by one-way analysis of variance 
(ANOVA) with the Bonferroni post hoc test 
using PRISMA (GraphPad Software, Inc., 
San Diego, CA, version 5.01). In both cases, 
p ≤ 0.05 was used as the criterion for statis-
tical significance (sample vs. control).
rESULtS
in vitro effects of C. aromatisans and m. 
grandiflora on no production by mouse 
peritoneal macrophages
In the present study, it was observed that 
the extracts of C. aromatisans and M. 
grandiflora inhibited NO production in a 
concentration-dependent manner (fig. 1). 
The highest activity was found for the non-
polar extract of C. aromatisans (cahx). 
This extract almost completely inhibited 
NO production (97.58% inhibition) by pe-
ritoneal macrophages at the concentrations 
of 500 and 1000 µg/mL. No effects on the 
viability of peritoneal macrophages exposed 
to different concentrations of extracts were 
observed, indicating the potential specifi-
city of the extracts for NO production by 
macrophages
cell viability
cell viability was evaluated using the mi-
tochondrial-dependent reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) to purple formazan. It 
was showed that the treatments with 1, 10, 
100, 500 and 1000 µg/mL with the extracts 
did not alter the viability of mice peritoneal 
macrophages.
in vivo anti-inflammatory effects
In the carrageenan-induced hind paw oede-
ma model (table 1), the non-polar (CAhx) 
and polar extracts (CAacn) of C. aromati-
sans at the dose of 200 mg/kg resulted in the 
maximum inhibition (92 and 96%, respecti-
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fig. 1. Effect of CAacn, CAhx (Fig. 1A) and MAacn, MGhx (Fig. 1B) on NO production 
after 72 h of activated mouse peritoneal macrophages. Control (-) represent non activa-
ted peritoneal macrophages. LPS represents activated peritoneal macrophages with LPS 
without extracts treatments. NO production by LPS activated peritoneal macrophages 
was significantly (*p < 0.05) inhibited when different concentration (1, 10, 100, 500, 
1000 µg/mL) of extracts were added. Data represent mean ± S.D. values from the three 
independent experiments.
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vely) of paw oedema at 3 h after carrageenan 
injection. Similar results were obtained for 
the TPA-Induced mouse ear oedema model 
(table 2), in which both extracts of C. aro-
matisans showed anti-inflammatory effects 
of up to 80% at the same dose. these effects 
were similar in both cases to the effects of 
the anti-inflammatory drug indomethacin. In 
contrast, the extracts obtained from M. gran-
diflora showed lower values of reduction of 
inflammation in the carrageenan-induced 
hind paw oedema model (table 2). In the 
TPA-induced mouse ear oedema model, no 
anti-inflammatory effect was observed for 
the non-polar or polar extract of M. grandi-
flora at the dose of 200 mg/kg.
Acute toxicity
In the acute toxicity test, the four groups 
treated with the extracts of C. aromatisans 
and M. grandiflora showed no signs of ad-
verse effects, abnormal behaviour, toxicity 
or lethality at the dose of 200 mg/kg 72 h 
after administration.
Gc-ms
Gas chromatography-mass spectrometry 
analysis of the non-polar extracts of C. 
aromatisans and M. grandiflora showed that 
they were primarily composed of fatty acids 
and terpenoids (Figure S1-S22); C. aroma-
tisans registered four major compounds at 
retention times (RT) of 7.51, 10.01, 10.94 
and 20.57 min (Figure S1 in supplementary 
material) which included 2H-1-benzo-
pyran-2-one, isolongifolen-5-one, methyl 
palmitate and Lup-20 (29)-en-3-ol, acetate, 
respectively (figure S2, S5, S7, S11). Other 
minor components were identified as ledol, 
2-pentadecanone, stigmasterol, lupeol and 
β-sitosterol. M. grandiflora contained six 
main compounds at rt of 8.64, 17.17, 20.09, 
20.49, 21.44 and 21.59 min (figures S14, 
S17-S19, S21,S22 in supplementary mate-
rial) with mass fragmentation pattern similar 
to caryophyllene oxide, hentriacontane, 12-
Oleanen-3-yl acetate, Lup-20 (29)-en-3-ol, 
acetate. Compounds with retention times at 
21.44 and 21.58 min were not found in the 
NIST library (figures S21 and S22). 
dIScUSSION
Different models were used to evaluate 
the anti-inflammatory effects of C. aro-
matisans and M. grandiflora. the in vitro 
experiments were performed using the ni-
tric oxide test. It is well known that during 
an inflammatory process, after signalling 
events, macrophages induce the expression 
of pro-inflammatory enzymes such as in-
ducible nitric oxide synthase (iNOS). This 
enzyme is regulated by the secretion of 
pro-inflammatory cytokines and produces 
NO from L-arginine. Large amounts of NO 
can cause severe collateral damage in the 
tissue because NO can form peroxynitrite 
(ONOO-), a cytotoxic molecule related to 
inflammatory pathologies. For this reason, 
the regulation of the production of NO is an 
important target for inflammatory diseases 
(Guzik et al., 2003).
the in vivo anti-inflammatory effects of 
the extracts were measured using the ca-
rrageenan-induced hind paw oedema and 
TPA-induced ear oedema models. These two 
models are well-known indicators of acute 
inflammation, and both evaluations can be 
performed at the same time because they use 
the same animals and the same treatment 
doses. In addition, both models allow the 
rapid evaluation of the effect of an extract or 
compound with potential anti-inflammatory 
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properties. When the polysaccharide carra-
geenan is injected into the hind paw, it pro-
duces oedema mediated by white blood cells 
(neutrophils, monocytes and lymphocytes), 
major inflammatory mediators such as NO, 
prostaglandin E2 (PGE2) and the cytokines 
TNF-α and IL-6 (Kim, et al., 2012). tPa is a 
topical oedematogenic agent and causes skin 
irritation and tumour promotion, because it 
stimulates PKC, which plays a critical role in 
signal transduction pathways and regulates 
cell growth and differentiation (Nishizuka, 
1992). TPA affects the membrane, resulting 
in altered cell adhesion and the induction of 
arachidonic acid metabolism, specifically 
causing the release of prostaglandins, which 
are responsible for oedema (Weinstein et al., 
1979). The results obtained in the present 
work, suggest that the different groups of 
anti-inflammatory metabolites of C. aroma-
tisans are distributed between both polari-
ties. Also, these results could indicate that 
the possible anti-inflammatory mechanism 
of MGhx (which showed an anti-inflamma-
tory effect only in the carrageenan model) 
does not involve the PKC pathway. Further 
in vitro experiments can elucidate the speci-
fic anti-inflammatory mechanism of MGhx. 
A literature search for C. aromatisans did 
not found any previous chemical study. A 
previous study of M. grandiflora revealed 
the presence of limonene, citronella, cam-
phene, pinene and phellandrene in essential 
oils prepared from the inflorescences, stems 
and leaves (Pérez-Amador et al., 2006). 
The compound 6β-hydroxy-germacradien-
8,12-olide (6-epi-desacetyllaurenobiolide) 
was obtained from the chloroform extract 
of M. grandiflora (Quijano et al., 1984). 
Different species of the Asteraceae family, 
including species of the genus Eupatorium, 
contain terpenoids, such as stigmasterol 
and taraxeryl acetate. Stigmasterol is able 
to reduce pro-inflammatory mediators such 
as NO and PGE2 in RAW 264.7 murine 
macrophages in vitro (Pandith et al., 2013). 
Taraxeryl acetate reduces inflammation in 
in vivo models such as hind paw oedema 
induced by carrageenan and mouse ear 
oedema induced by TPA (Pérez-García et 
al., 2005). In this preliminary evaluation 
of the non-polar extract of C. aromatisans, 
stigmasterol was found, but taraxeryl acetate 
was not. Stigmasterol has a known anti-
inflammatory effect, and other components 
of the non-polar extract may contribute to 
this effect in a synergistic manner. In the 
in vitro evaluation, it was observed that 
the extracts inhibited NO production in a 
concentration-dependent manner, and this 
activity might be responsible for their in 
vivo anti-inflammatory properties. However, 
considering that there exist different me-
diators that can be inhibited to produce the 
anti-inflammatory effect, further studies are 
necessary. The presence of terpenoids and 
fatty acids in the non-polar extracts could 
validate the use of this species in traditio-
nal medicine and the use of petrolatum to 
prepare the ointments. Because of its non-
polar composition, petrolatum would retain 
the non-polar compounds and essential oils 
from the leaves, and then it can be admi-
nistered topically. Due to these interesting 
results, the isolation and characterisation of 
the bioactive compounds in each plant are 
recommended. Based on the present work, 
it can be concluded that the non-polar and 
polar extracts of C. aromatisans and the 
non-polar extract of M. grandiflora possess 
in vitro and in vivo anti-inflammatory acti-
vities, and both species seem to be useful to 
treat inflammatory symptoms.
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cONcLUSION
The results obtained in the present study 
show fundaments to validate the traditional 
uses by Mayan communities that endorse 
the use of this species to treat inflammation. 
additionally, C. aromatisans has shown a 
stronger in vivo and in vitro activity, and 
one of the possible mechanisms of the anti-
inflammatory response is the inhibition of 
the NO production.
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fig. s1. Gas Chromatography profile of the n-hexanic extract of C. aromatisans.
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fig. s2. Mass spectrum of compound at RT = 7.508 min and its similar mass spectrum 
 pattern with 2H-1-Benzopyran-2-one (NIST library).
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fig. s3. Mass spectrum of compound at RT = 8.517 min and its similar mass spectrum 
pattern with 4H-Cycloprop [e]azulen-4-ol, decahydro-1,4,7-tetramethyl 
(NIST library).
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fig. s4. Mass spectrum of compound at RT=8.795 min and its similar mass spectrum 
 pattern with Ledol (NIST library).
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fig. s5. Mass spectrum of compound at RT = 10.010 min and its similar mass spectrum 
 pattern with isolongifolen-5-one (NIST library).
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fig. s6. Mass spectrum of compound at RT = 10.390 min and its similar mass spectrum 
 pattern with 2-Pentadecanone (NIST library).
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fig. s7. Mass spectrum of compound at RT = 10.931 min and its similar mass spectrum 
 pattern with Methyl palmitate (NIST library).
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fig. s8. Mass spectrum of compound at RT = 18.524 min and its similar mass spectrum 
 pattern with Stigmasterol (NIST library).
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fig. s9. Mass spectrum of compound at RT = 18.934 min and its similar mass spectrum 
 pattern with -Sitosterol (NIST library).
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fig. s10. Mass spectrum of compound at RT = 19.665 min and its similar mass 
        spectrum pattern with Lupeol (NIST library).
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fig. s11. Mass spectrum of compound at RT = 20.572 min and its similar mass 
        spectrum pattern with Lup-20 (29)-en-3-ol, acetate (NIST library).
309
Villa-De la Torre, F. et al.: Anti-inflammatory activity of Critonia aromatisans and Montanoa grandiflora leaves extracts.
ISSN 2395-9525 
fig. s12. Gas Chromatography profile of the n-hexanic extract of M. glandiflora.
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fig. s13. Mass spectrum of compound at RT = 8.576 min and its similar mass spectrum 
                                pattern with 4H-Cycloprop [e]azulen-4-ol, decahydro-1,4,7-tet-
ramethyl (NIST library).
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fig. s14. Mass spectrum of compound at RT = 8.634 min and its similar mass spectrum 
                                pattern with Caryophyllene oxide (NIST library).
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fig. s15. Mass spectrum of compound at RT = 11.356 min and its similar mass 
        spectrum pattern with Hexadecanoic acid, ethyl ester (NIST library).
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fig. s16. Mass spectrum of compound at RT = 12.131 min and its similar mass 
        spectrum pattern with Phytol (NIST library).
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fig. s17. Mass spectrum of compound at RT = 17.164 min and its similar mass 
spectrum pattern with Hentriacontane (NIST library).
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fig. s18. Mass spectrum of compound at RT = 20.075 min and its similar mass 
         spectrum pattern with 12-Oleanen-3-yl acetate (NIST library).
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fig. s19. Mass spectrum of compound at RT = 20.485 min and its similar mass 
        spectrum pattern with Lup-20 (29)-en-3-ol-acetate (NIST library).
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fig. s20. Mass spectrum of compound at RT = 20.572 min and its similar mass 
        spectrum pattern with Taraxasterol (NIST library).
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